Lebrec H - Search Results

1

Immunomodulation and lymphoma in humans.

Ponce RA, Gelzleichter T, Haggerty HG, Heidel S, Holdren MS, Lebrec H, Mellon RD, Pallardy M. Ponce RA, et al. Among authors: lebrec h. J Immunotoxicol. 2014 Jan-Mar;11(1):1-12. doi: 10.3109/1547691X.2013.798388. Epub 2013 Jun 7. J Immunotoxicol. 2014. PMID: 23746314 Free article. Review.

2

An inter-laboratory retrospective analysis of immunotoxicological endpoints in non-human primates: T-cell-dependent antibody responses.

Lebrec H, Cowan L, Lagrou M, Krejsa C, Neradilek MB, Polissar NL, Black L, Bussiere J. Lebrec H, et al. J Immunotoxicol. 2011 Jul-Sep;8(3):238-50. doi: 10.3109/1547691X.2011.587473. Epub 2011 Jun 21. J Immunotoxicol. 2011. PMID: 21692639 Free article.

3

Survey: immune function and immunotoxicity assessment in dogs.

Lebrec H, O'Lone R, Freebern W, Komocsar W, Moore P. Lebrec H, et al. J Immunotoxicol. 2012 Jan-Mar;9(1):1-14. doi: 10.3109/1547691X.2011.592163. Epub 2011 Nov 7. J Immunotoxicol. 2012. PMID: 22059464 Free article.

4

An inter-laboratory retrospective analysis of immunotoxicological endpoints in non-human primates: flow cytometry immunophenotyping.

Krejsa CM, Neradilek MB, Polissar NL, Cox N, Clark D, Cowan L, Bussiere J, Lebrec H. Krejsa CM, et al. Among authors: lebrec h. J Immunotoxicol. 2013 Oct-Dec;10(4):361-72. doi: 10.3109/1547691X.2012.755237. Epub 2013 Feb 6. J Immunotoxicol. 2013. PMID: 23384295 Free article. Review.

5

T-cell-dependent antibody responses in the rat: forms and sources of keyhole limpet hemocyanin matter.

Lebrec H, Hock MB, Sundsmo JS, Mytych DT, Chow H, Carlock LL, Joubert MK, Reindel J, Zhou L, Bussiere JL. Lebrec H, et al. J Immunotoxicol. 2014 Jul-Sep;11(3):213-21. doi: 10.3109/1547691X.2013.822948. Epub 2013 Aug 20. J Immunotoxicol. 2014. PMID: 23961896 Free article.

6

Tumor necrosis factor, tumor necrosis factor inhibition, and cancer risk.

Lebrec H, Ponce R, Preston BD, Iles J, Born TL, Hooper M. Lebrec H, et al. Curr Med Res Opin. 2015 Mar;31(3):557-74. doi: 10.1185/03007995.2015.1011778. Epub 2015 Feb 16. Curr Med Res Opin. 2015. PMID: 25651481 Review.

7

HESI/FDA workshop on immunomodulators and cancer risk assessment: Building blocks for a weight-of-evidence approach.

Lebrec H, Brennan FR, Haggerty H, Herzyk D, Kamperschroer C, Maier CC, Ponce R, Preston BD, Weinstock D, Mellon RD. Lebrec H, et al. Regul Toxicol Pharmacol. 2016 Mar;75:72-80. doi: 10.1016/j.yrtph.2015.12.018. Epub 2015 Dec 29. Regul Toxicol Pharmacol. 2016. PMID: 26743742 Free article.

8

Development of a BiTE^®-mediated CD8⁺ cytotoxic T-lymphocyte activity assay to assess immunomodulatory potential of drug candidates in Cynomolgus macaque.

Frank B, Wei YL, Kim KH, Guerrero A, Lebrec H, Balazs M, Wang X. Frank B, et al. Among authors: lebrec h. J Immunotoxicol. 2018 Dec;15(1):119-125. doi: 10.1080/1547691X.2018.1486342. J Immunotoxicol. 2018. PMID: 30241454 Free article.

9

Nonclinical safety assessment of engineered T cell therapies.

Lebrec H, Maier CC, Maki K, Ponce R, Shenton J, Green S. Lebrec H, et al. Regul Toxicol Pharmacol. 2021 Dec;127:105064. doi: 10.1016/j.yrtph.2021.105064. Epub 2021 Oct 14. Regul Toxicol Pharmacol. 2021. PMID: 34656748 Free article. Review.

10

Application of a newly-developed cynomolgus macaque BiTE-mediated cytotoxic T-lymphocyte activity assay to various immunomodulatory agents in vitro.

Frank B, Guo H, Lebrec H, Wang X. Frank B, et al. Among authors: lebrec h. J Immunotoxicol. 2021 Dec;18(1):154-162. doi: 10.1080/1547691X.2021.1992687. J Immunotoxicol. 2021. PMID: 34714999 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters